BPH - Benign Prostatic Enlargement - Results from #860

REVIEW UroToday

Meta-analysis and systematic review of intermediate-term follow-up of prostatic urethral lift for benign prostatic hyperplasia. February 23, 2020

Holmium laser enucleation of the prostate for the treatment of size-independent BPH: A single-center experience of 600 cases. February 23, 2020

To evaluate the efficacy and safety of different kinds of PDE5-Is with tamsulosin as a medical therapy for LUTS secondary to benign prostatic hyperplasia: A protocol for systematic review and meta analysis. February 17, 2020

The efficacy and safety of mirabegron on overactive bladder induced by benign prostatic hyperplasia in men receiving tamsulosin therapy: A systematic review and meta-analysis. February 17, 2020

Effect of Depth of Electroacupuncture on the IPSS of Patients with Benign Prostatic Hyperplasia. February 11, 2020

Critical Analysis of a Multicentric Experience with Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia: Outcomes and Complications of Ten Years of Routine Clinical Practice. February 9, 2020

National discrepancies in residency training of open simple prostatectomy for benign prostatic enlargement: Redefining our gold standard. February 2, 2020

Efficacy and safety of 1470-nm Diode Laser Enucleation of the Prostate in Individuals with Benign Prostatic Hyperplasia Continuously Administered Oral Anticoagulants or Antiplatelet Drugs. February 2, 2020

A randomized controlled study of the efficacy of tadalafil monotherapy versus combination of tadalafil and mirabegron for the treatment of persistent overactive bladder symptoms in men presenting with lower urinary tract symptoms (CONTACT Study). January 26, 2020

Effect of 5α-reductase inhibitors on the efficiency of thulium:yttrium-aluminium-garnet (RevoLix®) vaporesection for treating benign prostatic hyperplasia. January 26, 2020

Vaporization of Prostate by 160W GreenLight Laser on Postoperative Erectile Function-A Single Center Report. January 19, 2020

Study of phosphodiesterase 5 inhibitors and α-adrenoceptor antagonists used alone or in combination for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. January 19, 2020

The role of photovaporization of the prostate in small volume benign prostatic hyperplasia and review of the literature. January 14, 2020

Transperineal intraprostatic injection of botulinum neurotoxin A vs transurethral resection of prostate for management of lower urinary tract symptoms secondary to benign prostate hyperplasia: A prospective randomised study. January 14, 2020

Treatment preferences of patients with benign prostatic hyperplasia before and after using a web-based decision aid. January 13, 2020

Transurethral endoscopic enucleation of the prostate using a diode laser versus bipolar plasmakinetic for benign prostatic obstruction: a meta-analysis. January 12, 2020

Inter-imaging accuracy of computed tomography, magnetic resonance imaging, and transrectal ultrasound in measuring prostate volume compared to the anatomic prostatic weight. January 12, 2020

Prostatic Artery Embolization Using 100-300-μm Trisacryl Gelatin Microspheres to Treat Lower Urinary Tract Symptoms Attributable to Benign Prostatic Hyperplasia: A Single-Center Outcomes Analysis with Medium-Term Follow-up. January 12, 2020

Catheter management after benign transurethral prostate surgery: RAND/UCLA Appropriateness Criteria. January 11, 2020

Randomised Clinical Trial of Prostatic Artery Embolisation Versus a Sham Procedure for Benign Prostatic Hyperplasia. January 11, 2020

Page 44 of 140